Innovassynth Technologies (India) Ltd Q1 FY27 results (latest), Apr–Jun 2026 →See revenue, profit and what management said. You are viewing Q4 FY26.
IT

Innovassynth Technologies (India) Ltd

Q4 FY26Chemicals & Petrochemicals

Innovassynth Technologies (India) Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.

Innovassynth Technologies (India) Ltd Q4 FY26 key numbers

Revenue
Revenue from operations for the quarter ended 31-Mar-2026 was INR 5,083 lakhs, compared to INR 4,841 lakhs for the quarter ended 31-Mar-2025, showing a slight increase.

As stated in Innovassynth Technologies (India) Ltd's Q4 FY26 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.

Based on Innovassynth Technologies (India) Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹145
Market cap₹1.3K Cr

The short version

Revenue from operations for the quarter ended 31-Mar-2026 was INR 5,083 lakhs, compared to INR 4,841 lakhs for the quarter ended 31-Mar-2025, showing a slight increase. EBITDA for Q4 FY26: ₹628 lakhs, up from ₹1,040 lakhs in Q4 FY25 (down from last year’s figure, showing a decline).

From Innovassynth Technologies (India) Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Revenue from operations for the quarter ended 31-Mar-2026 was INR 5,083 lakhs, compared to INR 4,841 lakhs for the quarter ended 31-Mar-2025, showing a slight increase.
  • The year-on-year performance reflects a change considering the merger effective 1 Oct 2024; FY 25 figures represent only post-merger period from Oct 2024 to Mar 2025, so direct comparison has limitations.
  • The presentation states shipment delays and one-time inventory adjustment impacted the previous quarter but these factors are transitory.
  • Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility.

2 more points from Innovassynth Technologies (India) Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Innovassynth Technologies (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

- Life Sciences capacity expansion underway to double manufacturing capacity, aligned with CDMO demand growth (Page 6). - Capacity expansion and quality audit success support medium-term growth visibility (Page 6). - Focus is on expanding existing Life Sciences manufacturing capacity at Khopoli. - Continued capacity expansion linked to improved order book and business development (Pages 5-7). Summary: The presentation describes an ongoing Life Sciences manufacturing capacity expansion to double capacity, with timing aligned with CDMO demand growth, without specifying exact capex amounts or timelines.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Innovassynth Technologies (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The presentation reports an open order book value of approximately INR 176 crores (Page 7).
  • It highlights major orders received from USA-based companies with additional orders expected (Page 7).
  • During the quarter, the order book improved by about INR 60 crore, reflecting continued customer demand and enhanced revenue visibility (Page 5).
  • The company supports multiple customer molecules across development and commercialization stages, contributing to potential future manufacturing volumes and revenue growth (Page 5).

Innovassynth Technologies (India) Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2024Q1 FY25
Sep 2024Q2 FY25
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26

Q4 FY26 figures are not in this chart yet. Latest shown: Sep 2025 (Q2 FY26). The Q4 FY26 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q2 FY26): revenue ₹0 Cr, net loss ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Innovassynth Technologies's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Innovassynth Technologies (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Innovassynth Technologies (India) Ltd Q4 FY26 results?

Revenue from operations for the quarter ended 31-Mar-2026 was INR 5,083 lakhs, compared to INR 4,841 lakhs for the quarter ended 31-Mar-2025, showing a slight increase. EBITDA for Q4 FY26: ₹628 lakhs, up from ₹1,040 lakhs in Q4 FY25 (down from last year’s figure, showing a decline).

What is Innovassynth Technologies (India) Ltd share price analysis?

Innovassynth Technologies (India) Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,338 Cr. Investors should review the full earnings analysis for detailed insights.

Is Innovassynth Technologies (India) Ltd planning capital expenditure?

Life Sciences capacity expansion underway to double manufacturing capacity, aligned with CDMO demand growth (Page 6).

Keep Innovassynth Technologies (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.